Advertisement

Topics

More News! Merck KGaA to drop Biosimilars? Sanofi buys into RSV

06:00 EST 10 Mar 2017 | Labiotech.eu

Try as we might, we can’t cover all the biotech news out there! Here’s a roundup of news that didn’t make the cut this week. Merck KGaA might jettison its biosimilar R&D program in the face of increasing competition AstraZeneca will grant Sanofi access to ...

This awesome article More News! Merck KGaA to drop Biosimilars? Sanofi buys into RSV appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: More News! Merck KGaA to drop Biosimilars? Sanofi buys into RSV

NEXT ARTICLE

More From BioPortfolio on "More News! Merck KGaA to drop Biosimilars? Sanofi buys into RSV"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...